Singapore markets closed

Nabriva Therapeutics plc (NBRVF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0000-0.0001 (-99.00%)
At close: 11:44AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-55,054
-57,185
-49,450
-69,484
-82,764
Depreciation & amortisation
101
217
637
820
770
Deferred income taxes
-
-
-
-
0
Stock-based compensation
1,730
1,967
3,291
5,219
9,748
Change in working capital
27,793
13,733
-14,857
-11,391
-195
Accounts receivable
10,901
9,015
-8,117
-5,887
2,582
Inventory
8,004
4,833
-8,686
-5,141
-682
Accounts payable
12,953
1,093
1,581
-1,813
1,310
Other working capital
-13,024
-36,922
-59,582
-71,444
-71,953
Other non-cash items
4,990
4,557
822
748
549
Net cash provided by operating activities
-12,909
-36,711
-59,557
-71,331
-71,892
Cash flows from investing activities
Investments in property, plant and equipment
-115
-211
-25
-113
-61
Acquisitions, net
-
-
-
0
0
Purchases of investments
-
-
-
0
0
Other investing activities
-49
-52
-56
-161
392
Net cash used for investing activities
-164
-263
-81
-274
331
Cash flows from financing activities
Debt repayment
-6,825
-2,921
0
-30,000
0
Common stock issued
77
2,123
27,911
53,460
20,138
Other financing activities
2,345
3,055
38,455
2,756
25,585
Net cash used provided by (used for) financing activities
-4,403
1,851
66,366
26,924
56,075
Net change in cash
-17,908
-35,297
6,244
-44,821
-15,592
Cash at beginning of period
20,163
47,834
41,590
86,411
102,003
Cash at end of period
2,687
12,537
47,834
41,590
86,411
Free cash flow
Operating cash flow
-12,909
-36,711
-59,557
-71,331
-71,892
Capital expenditure
-115
-211
-25
-113
-61
Free cash flow
-13,024
-36,922
-59,582
-71,444
-71,953